WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
WST on NYSE
Shares outstanding
71,941,794
Price per share
$275.14
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
68,660,523
Total reported value
$17,958,123,664
% of total 13F portfolios
0.01%
Share change
-1,156,785
Value change
-$186,326,960
Number of holders
746
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 13% $2,545,899,009 9,704,948 The Vanguard Group 30 Sep 2025
BlackRock, Inc. 8.4% $1,222,288,672 6,066,852 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 746 institutional investors reported holding 68,660,523 shares of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST). This represents 95% of the company’s total 71,941,794 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) together control 63% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 13% 9,704,948 +4.2% 0.04% $2,545,899,009
BlackRock, Inc. 9% 6,455,861 -2.3% 0.03% $1,693,566,022
STATE STREET CORP 4.5% 3,207,911 -2% 0.03% $841,531,293
Bank of New York Mellon Corp 4% 2,904,709 -9.4% 0.14% $761,992,358
Artisan Partners Limited Partnership 3.9% 2,770,920 +22% 1% $726,895,444
BROWN ADVISORY INC 3.5% 2,498,082 -17% 0.85% $655,329,708
GEODE CAPITAL MANAGEMENT, LLC 2.6% 1,857,124 +1.3% 0.03% $485,197,258
MORGAN STANLEY 2.1% 1,478,629 -0.44% 0.02% $387,889,624
VAN ECK ASSOCIATES CORP 2% 1,424,879 -4.1% 0.35% $373,789,000
APG Asset Management N.V. 2% 1,413,698 -15% 0.89% $315,621,614
Durable Capital Partners LP 1.6% 1,172,583 +13% 2.3% $307,603,698
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1.4% 1,038,094 -1.3% 0.66% $272,323,326
GENERATION INVESTMENT MANAGEMENT LLP 1.4% 976,014 -16% 1.7% $256,037,753
FRANKLIN RESOURCES INC 1.3% 965,931 -13% 0.06% $253,392,682
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 1.2% 885,236 -15% 0.05% $232,223,960
Invesco Ltd. 1.2% 881,285 -8.2% 0.04% $231,187,494
Findlay Park Partners LLP 1.1% 802,106 -1.8% 2.2% $210,416,467
NORTHERN TRUST CORP 1% 744,891 -0.67% 0.02% $195,407,256
CITADEL ADVISORS LLC 1% 727,537 +465% 0.15% $190,854,781
T. Rowe Price Investment Management, Inc. 0.97% 701,415 +50% 0.11% $184,003,000
Point72 Asset Management, L.P. 0.92% 659,253 +94% 0.38% $172,942,016
ProShare Advisors LLC 0.85% 612,620 -17% 0.34% $160,708,605
TD Asset Management Inc 0.84% 606,332 +26% 0.13% $159,059,073
ROYAL BANK OF CANADA 0.78% 559,775 +2.9% 0.03% $146,846,000
AQR CAPITAL MANAGEMENT LLC 0.76% 545,879 +420% 0.09% $142,949,255

Institutional Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,492,564 $407,169,310 -$3,947,704 $275.14 114
2025 Q3 68,660,523 $17,958,123,664 -$186,326,960 $262.33 746
2025 Q2 70,038,330 $15,270,649,646 +$210,523,947 $218.80 724
2025 Q1 68,781,560 $15,368,679,288 -$323,502,271 $223.88 699
2024 Q4 69,650,381 $22,801,911,569 +$487,991,876 $327.56 733
2024 Q3 67,626,281 $20,228,293,870 -$216,209,584 $300.16 722
2024 Q2 68,348,443 $22,454,791,550 +$203,409,565 $329.39 766
2024 Q1 67,709,439 $26,709,457,585 -$227,433,059 $395.71 772
2023 Q4 622,954 $219,354,367 -$17,847,876 $352.12 8
2023 Q3 66,961,663 $25,129,114,916 +$166,241,652 $375.21 742
2023 Q2 67,226,025 $25,621,581,378 -$805,330,933 $382.47 715
2023 Q1 65,847,042 $22,747,483,408 +$353,737,179 $346.47 672
2022 Q4 68,973,266 $16,237,439,222 +$15,801,582 $235.35 614
2022 Q3 68,071,838 $16,777,906,026 -$360,225,113 $246.08 605
2022 Q2 68,095,150 $20,485,039,471 -$169,571,363 $302.37 630
2022 Q1 67,888,556 $27,778,893,094 -$2,815,994 $410.71 685
2021 Q4 67,727,308 $31,581,885,563 +$703,952,861 $469.01 711
2021 Q3 66,075,548 $27,908,699,644 -$686,245,852 $424.54 659
2021 Q2 68,379,380 $24,416,195,362 +$165,122,717 $359.10 624
2021 Q1 67,688,546 $18,973,802,811 +$70,217,298 $281.78 577
2020 Q4 68,620,081 $19,377,529,524 +$199,394,101 $283.31 574
2020 Q3 66,060,530 $18,137,648,891 -$198,196,422 $274.90 558
2020 Q2 67,875,190 $15,519,259,071 +$456,073,916 $227.17 508
2020 Q1 66,623,780 $10,146,648,962 -$43,431,012 $152.25 451
2019 Q4 67,505,257 $10,146,035,323 +$89,925,160 $150.33 434
2019 Q3 67,070,687 $9,511,258,981 -$50,961,217 $141.82 395
2019 Q2 67,209,694 $8,408,602,591 +$89,368,343 $125.15 361
2019 Q1 67,782,438 $7,469,776,358 -$154,328,537 $110.20 368
2018 Q4 69,260,364 $6,789,369,291 +$36,993,006 $98.03 341
2018 Q3 68,682,576 $8,479,650,317 +$105,273,098 $123.47 345
2018 Q2 68,983,756 $6,848,752,817 -$60,450,395 $99.29 312
2018 Q1 70,245,901 $6,201,570,320 +$35,298,392 $88.29 321
2017 Q4 69,681,834 $6,874,987,375 -$50,678,482 $98.67 330
2017 Q3 69,779,866 $6,715,625,721 +$236,113,782 $96.26 297
2017 Q2 67,249,642 $6,356,373,261 +$125,373,531 $94.52 308
2017 Q1 65,741,391 $5,366,348,783 +$388,444,808 $81.61 285
2016 Q4 66,245,233 $5,619,402,395 +$85,996,345 $84.83 280
2016 Q3 66,219,744 $4,931,309,183 +$54,113,324 $74.50 270
2016 Q2 65,274,788 $4,955,763,425 -$129,961,431 $75.88 281
2016 Q1 65,235,997 $4,524,977,733 +$73,919,237 $69.32 239
2015 Q4 65,586,553 $3,949,291,648 -$8,118,514 $60.22 242
2015 Q3 67,516,660 $3,654,013,595 +$3,552,146 $54.12 245
2015 Q2 66,577,244 $3,866,684,772 +$17,938,823 $58.08 216
2015 Q1 67,156,266 $4,039,842,972 +$107,556,054 $60.21 211
2014 Q4 65,563,551 $3,490,060,017 -$15,363,280 $53.24 221
2014 Q3 66,150,209 $2,960,879,964 +$86,227,110 $44.76 212
2014 Q2 64,479,693 $2,719,712,820 +$34,736,013 $42.18 220
2014 Q1 63,617,382 $2,802,353,916 +$37,288,118 $44.05 222